2,3-Bis(3,4-dimethoxybenzyl)butyrolactoneCAS# 25488-59-9 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 25488-59-9 | SDF | Download SDF |
PubChem ID | 384877 | Appearance | Powder |
Formula | C22H26O6 | M.Wt | 386.4 |
Type of Compound | Lignans | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (3R,4R)-3,4-bis[(3,4-dimethoxyphenyl)methyl]oxolan-2-one | ||
SMILES | COC1=C(C=C(C=C1)CC2COC(=O)C2CC3=CC(=C(C=C3)OC)OC)OC | ||
Standard InChIKey | SNAOLIMFHAAIER-DLBZAZTESA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. trans-2,3-Bis(3,4-dimethoxybenzyl)-gamma-butyrolactone is capable of inhibiting Na+,K+-ATPase activity with IC50 at a concentration less than 5 x 10(-4) M, it also shows [3H]ouabain displacement activity with IC50 at a concentration of 10(-4)-10(-3) M. |
Targets | Sodium Channel | ATPase | Potassium Channel |
2,3-Bis(3,4-dimethoxybenzyl)butyrolactone Dilution Calculator
2,3-Bis(3,4-dimethoxybenzyl)butyrolactone Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.588 mL | 12.94 mL | 25.8799 mL | 51.7598 mL | 64.6998 mL |
5 mM | 0.5176 mL | 2.588 mL | 5.176 mL | 10.352 mL | 12.94 mL |
10 mM | 0.2588 mL | 1.294 mL | 2.588 mL | 5.176 mL | 6.47 mL |
50 mM | 0.0518 mL | 0.2588 mL | 0.5176 mL | 1.0352 mL | 1.294 mL |
100 mM | 0.0259 mL | 0.1294 mL | 0.2588 mL | 0.5176 mL | 0.647 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Curryangine
Catalog No.:BCN7907
CAS No.:25488-37-3
- Talsupram hydrochloride
Catalog No.:BCC7924
CAS No.:25487-28-9
- Emricasan
Catalog No.:BCC5367
CAS No.:254750-02-2
- 2-MPPA
Catalog No.:BCC7995
CAS No.:254737-29-6
- Demethyleneberberine
Catalog No.:BCN2829
CAS No.:25459-91-0
- H-Asn-OtBu
Catalog No.:BCC2877
CAS No.:25456-86-4
- H-D-Glu-OtBu
Catalog No.:BCC2938
CAS No.:25456-76-2
- Felbamate
Catalog No.:BCC4904
CAS No.:25451-15-4
- (+)-Afzelechin
Catalog No.:BCN5121
CAS No.:2545-00-8
- Dehydropitavastatin ethyl ester
Catalog No.:BCC8931
CAS No.:254452-91-0
- H-Cys(pMeOBzl)-OH
Catalog No.:BCC2909
CAS No.:2544-31-2
- Phellopterin
Catalog No.:BCN2637
CAS No.:2543-94-4
- Kushenol W
Catalog No.:BCN3307
CAS No.:254886-76-5
- Kushenol X
Catalog No.:BCN3350
CAS No.:254886-77-6
- 4-Allyloxy-2-hydroxybenzophenone
Catalog No.:BCC8675
CAS No.:2549-87-3
- Tasquinimod
Catalog No.:BCC1987
CAS No.:254964-60-8
- 3-Epioleanolic acid
Catalog No.:BCN3050
CAS No.:25499-90-5
- 4-Phenylbutan-2-one
Catalog No.:BCN3808
CAS No.:2550-26-7
- 1-Acetyl-4-piperidinecarboxylic acid
Catalog No.:BCC8447
CAS No.:25503-90-6
- Bruceine B
Catalog No.:BCN7615
CAS No.:25514-29-8
- Bruceine C
Catalog No.:BCN8000
CAS No.:25514-30-1
- Bruceine A
Catalog No.:BCC5311
CAS No.:25514-31-2
- Ibotenic acid
Catalog No.:BCC6591
CAS No.:2552-55-8
- Isoferulic acid
Catalog No.:BCN5122
CAS No.:25522-33-2
A chemoenzymatic synthesis of both enantiomers of a cis-lignan lactone.
Tetrahedron: Asymmetry.1998 August;9(16):2827–2831.
The stereoselective acetylation of meso-2,3-bis(3,4-dimethoxybenzyl)butanediol by vinyl acetate in the presence of Candida antarctica lipase in benzene gave the corresponding (+)-(2S,3R) monoester (ee ≥98%). Transesterification of meso-2,3-bis(3,4-dimethoxybenzyl)butyl diacetate, in the presence of the same enzyme, by ethanol in benzene/isopropyl ether gave the corresponding (−)-(2R,3S) monoester (ee ≥98%). Both enantiomers of the known cis-2,3-Bis(3,4-dimethoxybenzyl)butyrolactone were synthesized from these monoesters.